Commonwealth Equity Services, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

$70.7 Billion
Q1 2025

A detailed history of Commonwealth Equity Services, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 41,575 shares of CPRX stock, worth $934,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,575

Previous 39,331 5.71%

Holding current value

$934,606

Previous $821,000 22.78%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$19.53 - $25.74 $43,825 - $57,760	2,244 Added 5.71%	41,575 $1.01 Million
Q4 2024 Feb 10, 2025	BUY	$19.73 - $23.93 $443,037 - $537,348	22,455 Added 133.06%	39,331 $821,000
Q3 2024 Oct 18, 2024	SELL	$15.19 - $21.35 $30,729 - $43,191	-2,023 Reduced 10.7%	16,876 $335,000
Q2 2024 Jul 31, 2024	SELL	$14.68 - $16.92 $10,041 - $11,573	-684 Reduced 3.49%	18,899 $293,000
Q1 2024 Apr 29, 2024	SELL	$13.18 - $17.11 $8,408 - $10,916	-638 Reduced 3.16%	19,583 $312,000
Q4 2023 Feb 06, 2024	BUY	$11.78 - $17.29 $35,822 - $52,578	3,041 Added 17.7%	20,221 $340,000
Q3 2023 Oct 23, 2023	SELL	$11.69 - $15.02 $79,772 - $102,496	-6,824 Reduced 28.43%	17,180 $201,000
Q2 2023 Aug 10, 2023	BUY	$11.5 - $18.08 $38,640 - $60,748	3,360 Added 16.28%	24,004 $323,000
Q1 2023 May 11, 2023	BUY	$14.34 - $21.05 $5,850 - $8,588	408 Added 2.02%	20,644 $342,000
Q4 2022 Feb 07, 2023	BUY	$12.25 - $19.5 $52,895 - $84,201	4,318 Added 27.13%	20,236 $376,000
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $15,764 - $34,656	2,233 Added 16.32%	15,918 $204,000
Q2 2022 Jul 19, 2022	BUY	$6.23 - $8.57 $17,973 - $24,724	2,885 Added 26.71%	13,685 $95,000
Q1 2022 May 04, 2022	SELL	$5.31 - $8.31 $10,912 - $17,077	-2,055 Reduced 15.99%	10,800 $89,000
Q4 2021 Jan 31, 2022	BUY	$5.21 - $7.45 $3,339 - $4,775	641 Added 5.25%	12,855 $87,000
Q3 2021 Oct 29, 2021	BUY	$4.85 - $6.04 $5,616 - $6,994	1,158 Added 10.47%	12,214 $64,000
Q1 2021 May 04, 2021	SELL	$3.45 - $4.69 $4,343 - $5,904	-1,259 Reduced 10.22%	11,056 $50,000
Q4 2020 Feb 11, 2021	SELL	$2.97 - $3.83 $2,970 - $3,830	-1,000 Reduced 7.51%	12,315 $41,000
Q2 2020 Aug 12, 2020	SELL	$3.48 - $5.05 $10,440 - $15,150	-3,000 Reduced 18.39%	13,315 $61,000
Q3 2019 Oct 30, 2019	SELL	$3.89 - $7.43 $3,890 - $7,430	-1,000 Reduced 5.78%	16,315 $86,000
Q2 2019 Jul 19, 2019	SELL	$2.7 - $6.11 $31,050 - $70,265	-11,500 Reduced 39.91%	17,315 $66,000
Q1 2019 May 13, 2019	BUY	$2.11 - $5.33 $2,110 - $5,330	1,000 Added 3.6%	28,815 $146,000
Q4 2018 Feb 11, 2019	BUY	$1.92 - $3.62 $6,720 - $12,670	3,500 Added 14.39%	27,815 $53,000
Q3 2018 Nov 06, 2018	SELL	$2.81 - $3.78 $1,405 - $1,890	-500 Reduced 2.01%	24,315 $91,000
Q4 2017 Feb 12, 2018	BUY	$2.51 - $4.4 $62,285 - $109,186	24,815	24,815 $97,000

Others Institutions Holding CPRX

# of Institutions

389

Shares Held

99.3M

Call Options Held

37K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.31B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Catalyst Pharmaceuticals, Inc. Transaction History